| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |